{"database": "openregs", "table": "documents", "rows": [["FDA-2012-N-0129-0014", "FDA", "FDA-2012-N-0129", "Agency Information Collection Activities; Proposed Additional Collection; Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications; Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants", "Notice", "60 Day Proposed Information Collection", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", "2020-01-22T04:59:59Z", "2019-11-22T14:28:29Z", "2019-25328", 0, 0, "0900006484197e92"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2012-N-0129-0014"], "units": {}, "query_ms": 0.3475239500403404, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}